ALL and AML cell lines showed a significantly higher dependence on the receptor tyrosine kinase FLT3 (Fig 2A), in line with the known importance of mutated FLT3 in AML and ALL [23–25]. This evidence concerns the gene FLT3 and acute myeloid leukemia.